References
- Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiological, and pathological evidence for sensory abnormalities in ALS. Neurology 2007; 69: 2236–42
- Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007; 6: 994–1003
- Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol 2005; 18: 487–93
- Beck M, Giess R, Magnus T, Puls I, Reiners K, Toyka KV, et al. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2002; 73: 68–70
- Toepfer M, Folwaczny C, Klauser A, Riepl RL, Muller-Felber W, Pongratz D. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1999; 1: 15–9
- Culebras A. Sleep and neuromuscular disorders. Neurol Clin 1996; 14: 791–805
- Hetta J, Jansson I. Sleep in patients with amyotrophic lateral sclerosis. J Neurol 1997; 244: S7–9
- Sforza E, Krieger J, Petiau C. REM sleep behaviour disorder: clinical and physiopathological findings. Sleep Med Rev 1997; 1: 57–69
- Thomas A, Bonanni L, Onofrj M. Symptomatic REM sleep behaviour disorder. Neurol Sci 2007; 28(Suppl 1)S21–36
- Baumann CR, Bassetti CL. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter. Sleep Med Rev 2005; 9: 253–68
- Eggermann E, Serafin M, Bayer L, Machard D, Saint-Mleux B, Jones BE, et al. Orexins/hypocretins excite basal forebrain cholinergic neurons. Neuroscience 2001; 108: 177–81
- Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996–10015
- Yamuy J, Fung SJ, Xi M, Chase MH. Hypocretinergic control of spinal cord motor neurons. J Neurosci 2004; 24: 5336–45
- Aziz, A, Fronczek, R, Maat-Schieman, M, Unmehopa, U, Roelandse, F, Overeem, S, , et al. Hypocretin and melanin-concentrating hormone in patients with Huntington's disease. Brain Pathol 2008, Published online 22 May 2008.
- Fronczek R, Overeem S, Lee SY, Hegeman IM, van Pelt J, van Duinen SG, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007; 130: 1577–85
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293–9
- Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553–62
- Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 2003; 184: 1010–6